These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 30836962)

  • 21. Risk Factors Associated with Urothelial Bladder Cancer.
    Alouini S
    Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The unveiling of a new risk factor associated with bladder cancer in Lebanon.
    Temraz S; Haibe Y; Charafeddine M; Saifi O; Mukherji D; Shamseddine A
    BMC Urol; 2019 Mar; 19(1):16. PubMed ID: 30836962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case-control study of the effects of trihalomethanes on urinary bladder cancer risk.
    Bove GE; Rogerson PA; Vena JE
    Arch Environ Occup Health; 2007; 62(1):39-47. PubMed ID: 18171646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union.
    Evlampidou I; Font-Ribera L; Rojas-Rueda D; Gracia-Lavedan E; Costet N; Pearce N; Vineis P; Jaakkola JJK; Delloye F; Makris KC; Stephanou EG; Kargaki S; Kozisek F; Sigsgaard T; Hansen B; Schullehner J; Nahkur R; Galey C; Zwiener C; Vargha M; Righi E; Aggazzotti G; Kalnina G; Grazuleviciene R; Polanska K; Gubkova D; Bitenc K; Goslan EH; Kogevinas M; Villanueva CM
    Environ Health Perspect; 2020 Jan; 128(1):17001. PubMed ID: 31939704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term exposure to trihalomethanes in drinking water and breast cancer in the Spanish multicase-control study on cancer (MCC-SPAIN).
    Font-Ribera L; Gràcia-Lavedan E; Aragonés N; Pérez-Gómez B; Pollán M; Amiano P; Jiménez-Zabala A; Castaño-Vinyals G; Roca-Barceló A; Ardanaz E; Burgui R; Molina AJ; Fernández-Villa T; Gómez-Acebo I; Dierssen-Sotos T; Moreno V; Fernandez-Tardon G; Peiró R; Kogevinas M; Villanueva CM
    Environ Int; 2018 Mar; 112():227-234. PubMed ID: 29289867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating Potential Increased Bladder Cancer Risk Due to Increased Bromide Concentrations in Sources of Disinfected Drinking Waters.
    Regli S; Chen J; Messner M; Elovitz MS; Letkiewicz FJ; Pegram RA; Pepping TJ; Richardson SD; Wright JM
    Environ Sci Technol; 2015 Nov; 49(22):13094-102. PubMed ID: 26489011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.
    Lakkis NA; Adib SM; Hamadeh GN; El-Jarrah RT; Osman MH
    Cancer Control; 2018; 25(1):1073274818789359. PubMed ID: 30027755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder Cancer and Water Disinfection By-product Exposures through Multiple Routes: A Population-Based Case-Control Study (New England, USA).
    Beane Freeman LE; Cantor KP; Baris D; Nuckols JR; Johnson A; Colt JS; Schwenn M; Ward MH; Lubin JH; Waddell R; Hosain GM; Paulu C; McCoy R; Moore LE; Huang AT; Rothman N; Karagas MR; Silverman DT
    Environ Health Perspect; 2017 Jun; 125(6):067010. PubMed ID: 28636529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of cancer in the Eastern Mediterranean region: The need for action.
    Kulhánová I; Bray F; Fadhil I; Al-Zahrani AS; El-Basmy A; Anwar WA; Al-Omari A; Shamseddine A; Znaor A; Soerjomataram I
    Cancer Epidemiol; 2017 Apr; 47():125-132. PubMed ID: 28268206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of bladder cancer.
    Malats N; Real FX
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):177-89, vii. PubMed ID: 25836927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
    Ferlay J; Soerjomataram I; Dikshit R; Eser S; Mathers C; Rebelo M; Parkin DM; Forman D; Bray F
    Int J Cancer; 2015 Mar; 136(5):E359-86. PubMed ID: 25220842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea.
    Park S; Jee SH; Shin HR; Park EH; Shin A; Jung KW; Hwang SS; Cha ES; Yun YH; Park SK; Boniol M; Boffetta P
    BMC Cancer; 2014 Jun; 14():406. PubMed ID: 24902960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018.
    Shamseddine A; Saleh A; Charafeddine M; Seoud M; Mukherji D; Temraz S; Sibai AM
    Popul Health Metr; 2014 Mar; 12(1):4. PubMed ID: 24593777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personal habits and indoor combustions.
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
    IARC Monogr Eval Carcinog Risks Hum; 2012; 100(Pt E):1-538. PubMed ID: 23193840
    [No Abstract]   [Full Text] [Related]  

  • 35. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010.
    Parkin DM; Boyd L; Walker LC
    Br J Cancer; 2011 Dec; 105 Suppl 2(Suppl 2):S77-81. PubMed ID: 22158327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between smoking and risk of bladder cancer among men and women.
    Freedman ND; Silverman DT; Hollenbeck AR; Schatzkin A; Abnet CC
    JAMA; 2011 Aug; 306(7):737-45. PubMed ID: 21846855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case-control studies.
    Costet N; Villanueva CM; Jaakkola JJ; Kogevinas M; Cantor KP; King WD; Lynch CF; Nieuwenhuijsen MJ; Cordier S
    Occup Environ Med; 2011 May; 68(5):379-85. PubMed ID: 21389011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality assessment of various bottled waters marketed in Lebanon.
    Semerjian LA
    Environ Monit Assess; 2011 Jan; 172(1-4):275-85. PubMed ID: 20148363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): the case for Lebanon.
    Saade G; Warren CW; Jones NR; Asma S; Mokdad A
    Prev Med; 2008 Sep; 47 Suppl 1():S15-9. PubMed ID: 18590759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
    Amado RG; Wolf M; Peeters M; Van Cutsem E; Siena S; Freeman DJ; Juan T; Sikorski R; Suggs S; Radinsky R; Patterson SD; Chang DD
    J Clin Oncol; 2008 Apr; 26(10):1626-34. PubMed ID: 18316791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.